Detalhe da pesquisa
1.
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 16, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166764
2.
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 136, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765293
3.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133230
4.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol
; 18(23): 2573-2582, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734870
5.
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
J Oncol Pharm Pract
; 28(1): 215-221, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134568
6.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci
; 52(4): 1022-1032, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326360
7.
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Int J Clin Oncol
; 26(8): 1506-1513, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023933
8.
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 114, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262962
9.
A practical 16-day desensitization protocol in lenalidomide-induced non-immediate hypersensitivity reactions.
Ann Allergy Asthma Immunol
; 123(4): 394-397, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31400463
10.
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 192, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849943
11.
Analysis of the factors associated with diagnostic skin test positivity in immediate-type hypersensitivity reactions due to proton pump inhibitors.
Allergy
; 74(6): 1187-1190, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632619
12.
Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients.
J Cancer Res Ther
; 20(1): 93-97, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554304
13.
Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study.
Medicine (Baltimore)
; 103(9): e37259, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428877
14.
Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
Medicine (Baltimore)
; 103(8): e37213, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38394499
15.
Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey.
J Cancer Res Ther
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261430
16.
Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?
J Cancer Res Ther
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261434
17.
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Eur Urol Open Sci
; 63: 71-80, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572300
18.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Sci Rep
; 14(1): 5820, 2024 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461209
19.
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine.
Eur J Breast Health
; 19(2): 128-133, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025570
20.
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression.
Sci Rep
; 13(1): 8779, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258548